Rare Disease and Orphan Drugs Journal

STM

Rare Disease and Orphan Drugs Journal (rdodj) is a member of and subscribes to the principles of STM. Authors of rdodj can reuse a certain quantity of article contents from the chargeable publications of other STM members for free in their submissions to rdodj.
ORCID

Rare Disease and Orphan Drugs Journal (rdodj) is a member of ORCID and MESAs system has been connected with ORCID. After submissions to rdodj are published, they will be automatically synchronized to the authors' ORCID accounts if the authors have connected their MESAs accounts with ORCID accounts. rdodj's reviewers can choose to synchronize their review records to their ORCID accounts when filling in review reports.
Crossref

Rare Disease and Orphan Drugs Journal is a member of Crossref, which makes research outputs easy to find, cite, link, assess, and reuse.
iThenticate

All submissions to Rare Disease and Orphan Drugs Journal are checked for plagiarism by iThenticate.
Check for updates

All published articles in Rare Disease and Orphan Drugs Journal are enriched with a record of the current article status.

Portico

All published articles will be preserved here permanently:
https://www.portico.org/

Subscribe